[go: up one dir, main page]

Magnusson, 1994 - Google Patents

Synthesis of glycosphingolipids and corresponding neoglycolipids

Magnusson, 1994

Document ID
14059832340594593928
Author
Magnusson G
Publication year
Publication venue
Advanced drug delivery reviews

External Links

Snippet

Glycolipids of animal origin have many important functions based on molecular recognition in vivo and the over-all shape of glycolipids has a profound influence on their aggregation behavior. This review discusses current methods of glycosphingolipid and neoglycolipid …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A61K47/48023—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound
    • A61K47/48046—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound the modifying agent being a lipid, e.g. a triglyceride; the modifying agent being a polyamine, e.g. spermine or spermidine
    • A61K47/48053—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound the modifying agent being a lipid, e.g. a triglyceride; the modifying agent being a polyamine, e.g. spermine or spermidine the modifying agent being a phospholipid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A61K47/48023—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound
    • A61K47/48092—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound the modifying agent linked to the pharmacologically or therapeutically active agent being a sugar, nucleoside, nucleotide, nucleic acid

Similar Documents

Publication Publication Date Title
Paulsen Haworth Memorial Lecture. Synthesis of complex oligosaccharide chains of glycoproteins
Meo et al. A stereoselective approach for the synthesis of α-sialosides
FI78707B (en) NYA GLYKOSIDER OCH GLYKOKONJUGATER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
Pekari et al. Synthesis of the Fully Phosphorylated GPI Anchor Pseudohexasaccharide of Toxoplasma g ondii
Hasegawa et al. Synthetic studies on sialoglycoconjugates 41: a facile total synthesis of ganglioside GM2
de Jong et al. Exploring and exploiting the reactivity of glucuronic acid donors
Düffels et al. Synthesis of high‐mannose type neoglycolipids: Active targeting of liposomes to macrophages in gene therapy
CA2197336A1 (en) Sialic acid/fucose based medicaments
Gege et al. Synthesis of the sialyl Lewis X epitope attached to glycolipids with different core structures and their selectin‐binding characteristics in a dynamic test system
Demchenko et al. A highly convergent synthesis of a complex oligosaccharide derived from group B type III Streptococcus
US5962434A (en) Compounds for stimulating nerve growth
SK281488B6 (en) Method for synthesizing a di-, tri- or higher oligosaccharide product
Magnusson Synthesis of glycosphingolipids and corresponding neoglycolipids
Ainge et al. Phosphatidylinositol mannosides: synthesis and adjuvant properties of phosphatidylinositol di-and tetramannosides
US5567684A (en) Synthetic ganglioside derivatives
Ekelöf et al. Synthesis of oligosaccharide structures from the lipopolysaccharide of Moraxella catarrhalis
Ghosh et al. Total synthesis of the repeating unit of Streptococcus pneumoniae zwitterionic polysaccharide Sp1
Thomann et al. Novel glycolipid TLR2 ligands of the type Pam2Cys-α-Gal: Synthesis and biological properties
Sardar et al. Convergent synthesis of sialyl LewisX-O-Core-1 threonine
Morrone-Pozzuto et al. Synthesis of oligosaccharides containing the S-Gal p (α1→ 3) Gal p unit, glycomimetic of the epitope recognized by lytic antibodies
Tanaka et al. Rapid synthesis of oligosaccharides based on one-pot glycosylation
Hasegawa et al. Synthetic Studies on Sialoglycoconjugates 23: Total Synthesis of Sialyl-α (2↠ 6)-Lactotetraosylceramide and Sialyl-α (2↠ 6)-Neolactotetraosylceramide
Hasegawa et al. Synthetic Studies on Sialoglycoconjugates 48: Total Synthesis of Gangliosides Gm1 and Gd1a
Ando et al. First total synthesis of α-(2→ 3)/α-(2→ 6)-disialyl lactotetraosyl ceramide and disialyl Lewis A ganglioside as cancer-associated carbohydrate antigens
Zhang et al. Synthesis of Double-Chain Bis-sulfone Neoglycolipids of the 2'-, 3'-, and 6'-Deoxyglobotrioses